Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Label date: 20260701 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Blocks reuptake of norepinephrine and dopamine into presynaptic neurons and increases their release; therapeutic mode in ADHD unknown.
On both cards: Common side effects — Decreased appetite; Headache; Dry mouth · Interactions — Antihypertensive drugs
Only on the Methylphenidate card: Used for — ADHD (ages 6 to 65) · Common side effects — Insomnia; Upper abdominal pain (pediatric) · Warnings — Serious cardiac disease; increased BP and heart rate; Psychiatric reactions (mania, psychosis); Pediatric growth suppression; priapism · Interactions — MAO inhibitors (hypertensive crisis); Halogenated anesthetics
Mechanism: Relatively weak inhibitor of neuronal norepinephrine and dopamine reuptake; does not inhibit serotonin reuptake or monoamine oxidase.
On both cards: Common side effects — Headache; Dry mouth
Only on the Bupropion card: Used for — Major depressive disorder in adults · Common side effects — Nausea; Insomnia; Dizziness · Warnings — Seizure risk (dose-related); Neuropsychiatric events in smoking cessation; Hypertension · Interactions — CYP2B6 inducers; CYP2D6 substrates (e.g. metoprolol); MAOIs
Mechanism: Prodrug of dextroamphetamine, a non-catecholamine sympathomimetic amine with CNS stimulant activity.
On both cards: Common side effects — Decreased appetite; Dry mouth
Only on the Lisdexamfetamine card: Used for — ADHD in adults and children aged 6 or older; Moderate-to-severe binge-eating disorder in adults · Common side effects — Insomnia; Irritability; Upper abdominal pain · Warnings — Serious cardiac disease; Increased blood pressure and heart rate; Growth suppression in children; Not indicated for weight loss; safety and effectiveness for obesity have not been established · Interactions — MAOIs (contraindicated); Urinary acidifying / alkalinizing agents
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Boxed warnings on related cards
Methylphenidate: High potential for abuse and misuse, which can lead to substance use disorder, addiction, overdose and death.
Capsera